Last updated: July 25, 2023
Sponsor: University Hospital, Toulouse
Overall Status: Active - Recruiting
Phase
N/A
Condition
Tourette's Syndrome
Schizotypal Personality Disorder (Spd)
Psychosis
Treatment
N/AClinical Study ID
NCT05966610
RC31/22/0517
2023-A00049-36
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- People with a diagnosis of schizophrenia according to the Diagnostic and StatisticalManual of Mental Disorders (DSM-V) criteria.
- Psychiatric medical situation judged clinically stable : no change of mainantipsychotic in treatment in last 15 days.
- People who has given his non-opposition
- Patients affiliated to a social security system
Exclusion
Exclusion Criteria:
- Previous meeting of the participant with one of the investigators involved in theclinical assessment and scoring of the study scales.
- Person with a moderate to severe intellectual disability (clinical criteria).
- Person with a neurological pathology with cognitive impact
- Patients with legal protection
Study Design
Total Participants: 12
Study Start date:
July 12, 2023
Estimated Completion Date:
September 01, 2024
Study Description
Connect with a study center
CHU Toulouse
Toulouse,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.